Testing effectiveness (Phase 2)Study completedNCT00838396
What this trial is testing
Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease
Who this might be right for
GERD
Indivior Inc. 58